Hummingbird Bioscience Holdings Limited
Home | Hummingbird Bioscience
Singapore, Singapore · Founded 2015 · $169.0M raised
- Headquarters
- Singapore
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- hummingbirdbioscience.com
- Total Funding
- $169.0M
- Last Round
- $125.0M Series CJan 2020
- Rounds
- 3
About
Hummingbird Bioscience is a Singapore-based precision biotherapeutics company with proprietary antibody and ADC platforms, developing precision therapeutics for cancer.
Summary
Hummingbird Bioscience Holdings Limited is a Biotech company based in Singapore, Singapore, founded in 2015. It has raised $169.0M in total across 3 rounds, most recently a $125.0M Series C round in Jan 2020. Investors include Polaris Partners, Novo Holdings A/S and Frazier Healthcare.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...